FDA Inspection
Goetze-Niemer Co IncGoetze-Niemer Co Inc – FDA Inspection, Mar 19, 2014
Record Details
This FDA Inspection record concerns Goetze-Niemer Co Inc, with an inspection on March 19, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Goetze-Niemer Co Inc
- Inspection Date
- March 19, 2014
- Product Type
- Biologics
View Company Profile
ID · f2752d20-90b9-4cbf-8ff4-600639736e87
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 870748
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.260(e)Temperature limits
- 21 CFR 1271.320(a)Procedures re complaints
- 21 CFR 1271.200(c)Calibration procedures and schedules (general)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Goetze-Niemer Co Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2020 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 8, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 14, 2015 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Goetze-Niemer Co Inc
- FDA Inspection 1119118 - 2020-02-05
- FDA Inspection 1044414 - 2018-03-08
- FDA Inspection 952168 - 2015-12-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.